Bank of New York Mellon Corp - AGEX THERAPEUTICS INC ownership

AGEX THERAPEUTICS INC's ticker is AGE and the CUSIP is 00848H108. A total of 53 filers reported holding AGEX THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of AGEX THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$57,000
-48.6%
61,1570.0%0.00%
Q4 2019$111,000
-2.6%
61,157
+5.7%
0.00%
Q3 2019$114,000
-50.4%
57,838
-7.8%
0.00%
Q2 2019$230,000
+25.7%
62,713
+38.7%
0.00%
Q1 2019$183,000
+33.6%
45,230
-1.6%
0.00%
Q4 2018$137,00045,9620.00%
Other shareholders
AGEX THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 2,997,156$1,654,1300.14%
Strategic Wealth Investment Group, LLC 86,440$60,5160.01%
Prescott General Partners LLC 185,185$102,2040.01%
Summit X, LLC 33,000$19,0150.01%
Beirne Wealth Consulting Services, LLC 18,000$9,9340.01%
Sigma Planning Corp 134,977$74,4940.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 169,770$93,6960.00%
UBS Group AG 13,502$7,4260.00%
NewEdge Advisors, LLC 1$00.00%
BNP PARIBAS FINANCIAL MARKETS 334$1840.00%
View complete list of AGEX THERAPEUTICS INC shareholders